The flavivirus methyltransferase (MTase) sequentially methylates the N7 and 2-O positions of the viral RNA cap (GpppA-RNA 3 m 7 GpppA-RNA 3 m 7 GpppAm-RNA), using S-adenosyl-L-methionine (AdoMet) as a methyl donor. We report here that sinefungin (SIN), an AdoMet analog, inhibits several flaviviruses through suppression of viral MTase. The crystal structure of West Nile virus MTase in complex with SIN inhibitor at 2.0-Å resolution revealed a flavivirus-conserved hydrophobic pocket located next to the AdoMet-binding site. The pocket is functionally critical in the viral replication and cap methylations. In addition, the N7 methylation efficiency was found to correlate with the viral replication ability. Thus, SIN analogs with modifications that interact with the hydrophobic pocket are potential specific inhibitors of flavivirus MTase.The genus Flavivirus in the family Flaviviridae is composed of more than 70 viruses (1). Many flaviviruses are arthropodborne and cause significant human disease. The four serotypes of Dengue virus (DENV), 5 yellow fever virus (YFV), West Nile virus (WNV), Japanese encephalitis virus, and tick-borne encephalitis virus, are categorized as global emerging pathogens and are also National Institutes of Health NIAID Priority Pathogens (2). The World Health Organization has estimated annual human cases of more than 50 million, 200,000, and 50,000 for DENV (3), YFV (4), and Japanese encephalitis virus (5), respectively. Approximately 2.5 billion people are at risk of DENV infection (3). Since 1999, WNV has spread rapidly throughout the Western Hemisphere (6). Vaccines for humans are currently available only for YFV, Japanese encephalitis virus, and tick-borne encephalitis virus (2). No clinically approved antiviral therapy is available for treatment of flavivirus infections. Therefore, the development of vaccines and antiviral agents for prevention and treatment of flavivirus infections is a clear public health priority (6).The flavivirus genomic RNA is single-stranded and of positive (i.e. mRNA) polarity. A type I cap (see details below) is present at the 5Ј end, followed by the conserved dinucleotide sequence 5Ј-AG-3Ј (m 7 GpppAmG) (7). The 3Ј end of the genome terminates with 5Ј-CU OH -3Ј rather than with a poly(A) tract (8). The viral genome is ϳ11 kb in length, consisting of a 5Ј UTR, a single long open reading frame (ORF), and a 3Ј UTR (9). The single ORF encodes a polyprotein that is co-and posttranslationally processed by viral and cellular proteases into three structural proteins (capsid (C), premembrane (prM), or membrane (M), and envelope (E)), and seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5) (10). The nonstructural proteins are assumed to be involved primarily in the replication of viral RNA, as components of a replicase complex. Among the NS proteins, NS3 is a multifunctional protein with activities of a serine protease, an RNA triphosphatase, a nucleoside triphosphatase, and a helicase (11-13); NS5 has the functions of an RNA-dependent RNA polymerase...